Sherlock S
Royal Free Hospital School of Medicine, London, U.K.
J Hepatol. 1995;22(1 Suppl):160-4.
The VI International Symposium on Viral Hepatitis was held in Madrid, Spain, 3-5 February 1994, under the chairmanship of Dr Vicente Carreño. Over 800 attended from more than 30 countries. Considerable advances have been made since the fifth conference, which was held in 1992. These relate particularly to the role of hepatitis B virus (HBV) mutants and hepatitis C virus (HCV) genotypes and the prolonged assessment of interferon and its side-effects. The role of newer antiviral drugs alone or in combination was stressed. Emphasis was on assessment by serum markers of the actual virus, HBV-DNA and HCV-RNA, rather than by nonspecific serum transaminase estimations.
第六届国际病毒性肝炎研讨会于1994年2月3日至5日在西班牙马德里举行，由维森特·卡雷诺博士担任主席。来自30多个国家的800多人参加了会议。自1992年举行的第五届会议以来，已取得了相当大的进展。这些进展尤其涉及乙型肝炎病毒（HBV）突变体和丙型肝炎病毒（HCV）基因型的作用，以及对干扰素及其副作用的长期评估。强调了新型抗病毒药物单独使用或联合使用的作用。重点是通过实际病毒的血清标志物HBV-DNA和HCV-RNA进行评估，而不是通过非特异性血清转氨酶估计值进行评估。
